시장보고서
상품코드
1764078

감염 관리용 의류 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 제품별, 최종 용도별, 지역별, 경쟁별 부문(2020-2030년)

Infection Control Apparel Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By End Use, By Region and Competition, 2020-2030F

발행일: | 리서치사: TechSci Research | 페이지 정보: 영문 185 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 감염 관리용 의류 시장은 2024년에는 173억 1,000만 달러에 달하며, 2030년에는 222억 9,000만 달러에 달하며, CAGR 4.50%로 성장할 것으로 예측됩니다.

COVID-19 팬데믹은 개인보호장비(PPE)에 대한 수요를 가속화하는 데 매우 중요한 역할을 했으며, 의료 및 비의료 부문에서 감염 관리용 의류의 보급을 촉진하는 데 중요한 역할을 했습니다. 감염 예방은 여전히 전 세계에서 중요한 관심사이기 때문에 이러한 모멘텀은 향후에도 시장 성장세를 유지할 것으로 예측됩니다.

시장 개요
예측 기간 2026-2030년
시장 규모 : 2024년 173억 1,000만 달러
시장 규모 : 2030년 222억 9,000만 달러
CAGR : 2025-2030년 4.50%
급성장 부문 격리 가운
최대 시장 북미

재료 과학과 섬유 공학의 발전으로 통기성, 체액 저항성, 항균 보호 등의 기능을 갖춘 의복이 개발되면서 감염 관리용 의류는 특히 고위험군 임상 현장에서 필수적인 제품으로 더욱 큰 견인력을 얻고 있습니다. 그러나 시장은 여전히 장애물에 직면하고 있으며, 특히 고급 보호복의 제조 및 조달과 관련된 높은 비용으로 인해 비용에 민감한 지역에서는 채택이 제한 될 수 있습니다.

주요 시장 성장 촉진요인

헬스케어 산업의 성장

주요 시장 과제

첨단 소재의 비용 상승

주요 시장 동향

E-Commerce 및 디지털 유통 플랫폼의 성장

목차

제1장 개요

제2장 조사 방법

제3장 개요

제4장 COVID-19가 세계의 감염 관리용 의류 시장에 미치는 영향

제5장 세계의 감염 관리용 의류 시장 전망

  • 시장 규모·예측
    • 금액별
  • 시장 점유율·예측
    • 제품별(격리 가운, 화학요법 가운, 실험실 가운, 재킷)
    • 최종 용도별(병원, 외래·외과 센터, 클리닉, 조사·진단 실험실 , 기타)
    • 지역별
    • 기업별(2024년)
  • 시장 맵

제6장 북미의 감염 관리용 의류 시장 전망

  • 시장 규모·예측
  • 시장 점유율·예측
  • 북미 : 국가별 분석
    • 미국
    • 멕시코
    • 캐나다

제7장 유럽의 감염 관리용 의류 시장 전망

  • 시장 규모·예측
  • 시장 점유율·예측
  • 유럽 : 국가별 분석
    • 프랑스
    • 독일
    • 영국
    • 이탈리아
    • 스페인

제8장 아시아태평양의 감염 관리용 의류 시장 전망

  • 시장 규모·예측
  • 시장 점유율·예측
  • 아시아태평양 : 국가별 분석
    • 중국
    • 인도
    • 한국
    • 일본
    • 호주

제9장 남미의 감염 관리용 의류 시장 전망

  • 시장 규모·예측
  • 시장 점유율·예측
  • 남미 : 국가별 분석
    • 브라질
    • 아르헨티나
    • 콜롬비아

제10장 중동 및 아프리카의 감염 관리용 의류 시장 전망

  • 시장 규모·예측
  • 시장 점유율·예측
  • 중동 및 아프리카 : 국가별 분석
    • 남아프리카공화국
    • 사우디아라비아
    • 아랍에미리트

제11장 시장 역학

  • 촉진요인
  • 과제

제12장 시장 동향과 발전

  • 합병과 인수
  • 제품 출시

제13장 혼란 : 분쟁, 팬데믹, 무역장벽

제14장 세계의 감염 관리용 의류 시장 : SWOT 분석

제15장 Porter's Five Forces 분석

  • 산업내의 경쟁
  • 신규 참여의 가능성
  • 공급업체의 힘
  • 고객의 힘
  • 대체품의 위협

제16장 경쟁 구도

  • 3M Company
  • DuPont de Nemours, Inc.
  • Cardinal Health, Inc.
  • Owens & Minor, Inc.
  • Medline Industries, Inc.
  • Lindstrom Group
  • Ansell Ltd
  • Delta Plus Group
  • Lakeland Industries Inc.
  • Protective Industrial Products, Inc.

제17장 전략적 제안

제18장 조사회사 소개·면책사항

KSA 25.07.16

The Global Infection Control Apparel Market was valued at USD 17.31 billion in 2024 and is projected to reach USD 22.29 billion by 2030, growing at a CAGR of 4.50%. The COVID-19 pandemic played a pivotal role in accelerating the demand for personal protective equipment (PPE), leading to the widespread adoption of infection control apparel across healthcare and non-healthcare sectors. As infection prevention remains a key concern worldwide, this momentum is expected to sustain future market growth.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 17.31 Billion
Market Size 2030USD 22.29 Billion
CAGR 2025-20304.50%
Fastest Growing SegmentIsolation Gowns
Largest MarketNorth America

Infection control apparel is gaining further traction due to advancements in material science and textile engineering, which are yielding garments with features such as breathability, fluid resistance, and antimicrobial protection-particularly vital in high-risk clinical settings. However, the market continues to face obstacles, especially the high costs tied to manufacturing and procuring advanced protective garments, which can limit adoption in cost-sensitive regions.

Key Market Drivers

Growth in Healthcare Industry

The global healthcare industry's expansion is a primary force behind the rising demand for infection control apparel. With annual revenues exceeding USD 4 trillion, the industry comprises several major segments, including pharmaceuticals and biotechnology (USD 850 billion) and medical technology and diagnostics (USD 400 billion). As healthcare systems scale up across both developed and developing regions, the volume of clinical activities, surgical procedures, and patient admissions has also surged, leading to increased implementation of infection control measures.

The prevalence of healthcare-associated infections (HAIs) further underlines the critical role of protective apparel. On average, one in ten hospitalized patients contracts an HAI, with rates significantly higher in low- and middle-income countries. Vulnerable populations, such as ICU patients, face even greater risks. In Europe, the overall burden of the six most common HAIs surpasses that of 32 other major infectious diseases combined, reinforcing the necessity for effective infection prevention strategies, including the use of high-quality protective clothing.

Key Market Challenges

Rising Cost of Advanced Materials

The rising cost of high-performance materials used in manufacturing infection control apparel is a significant hurdle in market growth. Products like surgical gowns, gloves, masks, and coveralls now incorporate specialized materials with features such as antimicrobial properties, enhanced fluid resistance, and breathability. These sophisticated fabrics-including multi-layer synthetics and coated nonwovens-are notably more expensive than traditional materials.

With global safety standards becoming more rigorous, manufacturers must invest in materials that meet stringent performance and regulatory criteria. This increase in production cost elevates end-product pricing, posing financial challenges for healthcare systems-especially in regions where budget constraints impact purchasing decisions.

Key Market Trends

Growth of E-Commerce and Digital Distribution Platforms

The expansion of e-commerce and digital distribution platforms is emerging as a transformative trend in the global infection control apparel market. As demand for PPE and infection control garments grows across healthcare and industrial sectors, manufacturers and suppliers are increasingly utilizing digital channels to reach broader customer bases and streamline procurement.

Notably, initiatives such as Toray Industries' collaboration with the Guinean government underscore the growing role of digital and global outreach in supporting infectious disease prevention. Online portals now allow hospitals and healthcare professionals to place orders more efficiently, track inventory in real-time, and access regulatory documentation-offering significant advantages over traditional supply chains.

Key Market Players

  • 3M Company
  • DuPont de Nemours, Inc.
  • Cardinal Health, Inc.
  • Owens & Minor, Inc.
  • Medline Industries, Inc.
  • Lindstrom Group
  • Ansell Ltd
  • Delta Plus Group
  • Lakeland Industries Inc.
  • Protective Industrial Products, Inc.

Report Scope

In this report, the Global Infection Control Apparel Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Infection Control Apparel Market, By Product:

  • Isolation Gowns
  • Chemotherapy Gowns
  • Lab Coats
  • Jackets

Infection Control Apparel Market, By End Use:

  • Hospitals
  • Ambulatory & Surgical Centers
  • Clinics
  • Research & Diagnostic Labs
  • Others

Infection Control Apparel Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Infection Control Apparel Market.

Available Customizations

Global Infection Control Apparel Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Infection Control Apparel Market

5. Global Infection Control Apparel Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Isolation Gowns, Chemotherapy Gowns, Lab Coats, Jackets)
    • 5.2.2. By End Use (Hospitals, Ambulatory & Surgical Centers, Clinics, Research & Diagnostic Labs, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Infection Control Apparel Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By End Use
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Infection Control Apparel Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By End Use
    • 6.3.2. Mexico Infection Control Apparel Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By End Use
    • 6.3.3. Canada Infection Control Apparel Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By End Use

7. Europe Infection Control Apparel Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By End Use
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Infection Control Apparel Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By End Use
    • 7.3.2. Germany Infection Control Apparel Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By End Use
    • 7.3.3. United Kingdom Infection Control Apparel Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By End Use
    • 7.3.4. Italy Infection Control Apparel Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By End Use
    • 7.3.5. Spain Infection Control Apparel Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By End Use

8. Asia Pacific Infection Control Apparel Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By End Use
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Infection Control Apparel Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By End Use
    • 8.3.2. India Infection Control Apparel Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By End Use
    • 8.3.3. South Korea Infection Control Apparel Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By End Use
    • 8.3.4. Japan Infection Control Apparel Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By End Use
    • 8.3.5. Australia Infection Control Apparel Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By End Use

9. South America Infection Control Apparel Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By End Use
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Infection Control Apparel Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By End Use
    • 9.3.2. Argentina Infection Control Apparel Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By End Use
    • 9.3.3. Colombia Infection Control Apparel Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By End Use

10. Middle East and Africa Infection Control Apparel Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By End Use
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Infection Control Apparel Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By End Use
    • 10.3.2. Saudi Arabia Infection Control Apparel Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By End Use
    • 10.3.3. UAE Infection Control Apparel Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Disruptions : Conflicts, Pandemics and Trade Barriers

14. Global Infection Control Apparel Market: SWOT Analysis

15. Porters Five Forces Analysis

  • 15.1. Competition in the Industry
  • 15.2. Potential of New Entrants
  • 15.3. Power of Suppliers
  • 15.4. Power of Customers
  • 15.5. Threat of Substitute Products

16. Competitive Landscape

  • 16.1. 3M Company
    • 16.1.1. Business Overview
    • 16.1.2. Company Snapshot
    • 16.1.3. Products & Services
    • 16.1.4. Financials (As Reported)
    • 16.1.5. Recent Developments
    • 16.1.6. Key Personnel Details
    • 16.1.7. SWOT Analysis
  • 16.2. DuPont de Nemours, Inc.
  • 16.3. Cardinal Health, Inc.
  • 16.4. Owens & Minor, Inc.
  • 16.5. Medline Industries, Inc.
  • 16.6. Lindstrom Group
  • 16.7. Ansell Ltd
  • 16.8. Delta Plus Group
  • 16.9. Lakeland Industries Inc.
  • 16.10. Protective Industrial Products, Inc.

17. Strategic Recommendations

18. About Us & Disclaimer

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제